Introduction Sepsis remains a major global healthcare challenge and a leading cause of critical illness and mortality. Characterised by life-threatening
INCACARE
Welcome To
Incacare Live
Incacare Live is an initiative by Concord Biotech to keep you updated with recent advances in critical care. The website shares information regarding incidences of opportunistic fungal infections in patients.
Concord Biotech is a vertically integrated, R&D driven biotechnological powerhouse manufacturing API’s and Finished formulations, offers products across diversified therapeutic segments.
Blog
INTENSIVE CARE UPDATES
The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis
Introduction Invasive candidiasis (IC) continues to be a major cause of morbidity and mortality among hospitalised patients, particularly those admitted
Time to Initiation of Antibiotic Therapy in Critically Ill Patients with Suspected Sepsis and Its Effect on Intensive Care Unit Mortality: Analysis Using Bayesian Approach
Introduction Sepsis is a life-threatening condition characterised by organ dysfunction resulting from a dysregulated host response to infection. In critically
Introduction Invasive candidiasis is a serious fungal infection seen in 2–10% of ICU patients, driven by Candida species that can
Introduction Pneumonia is common and potentially fatal, with CAP causing high hospitalizations and significant mortality. Its economic burden is substantial,
Creation of New Antimicrobial Peptides 3: Research Promises and Shortcomings
Introduction The studies presented in this issue collectively underscore the growing potential of novel peptides as foundations for next-generation antibacterial







